Search

The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024.

… Thursday, January 23, 2025 The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024. WOUND-Q is the latest of only 18 MDDTs that have earned the qualification since the MDDT program began in 2017. WOUND-Q contains

Thanks to a second opinion and minimally invasive surgery at MSK to remove tongue cancer, Karren Tyler is back home in Charlottesville, Virginia, cancer free and focused on giving back to other cancer patients.

… Monday, November 24, 2025 When Karren Tyler noticed a spot on the back of her tongue last year, she had it checked out by a doctor near her home in Charlottesville, Virginia, who told her it was probably nothing to worry about. But a week after having the spot removed and biopsied, Karren learned she

After developing a noninvasive nanosensor to detect the progression of fatty liver disease in mice, researchers at the Sloan Kettering Institute have determined that there is a long-term effect on liver macrophages from eating a high-fat and high-sugar diet, even after switching back to a normal diet.

… Friday, October 12, 2018 Bottom Line: After developing a noninvasive nanosensor to detect the progression of fatty liver disease in mice, researchers at the Sloan Kettering Institute have determined that there is a long-term effect on liver macrophages from eating a high-fat and high-sugar diet, even

Learn how a heralded clinical trial for rectal cancer led to Dr. Andrea Cercek of MSK meeting the 4-day-old newborn of her patient, who feared she could not get pregnant.

… Tuesday, November 7, 2023 “Would you like to hold my baby?” Kelly Spill’s question to  Andrea Cercek, MD , is a familiar one from any proud par­ent. But as they sat together surrounded by Kelly’s family on her porch in southern New Jersey, that simple question took on a much more poignant meaning. As

A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled antibody accurately identifies whether a patient has clear cell renal carcinoma - the most common and aggressive type of renal tumor - and arms the urologist with crucial information that will help determine whether surgery is needed.

… Tuesday, March 6, 2007 The ability to identify an individual’s specific tumor type prior to surgery could have important implications for the management of patients diagnosed with kidney cancer . A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled

Learn how noninvasive prenatal tests designed to screen for genetic abnormalities in the fetus may detect the presence of cancer in pregnant women.

… Monday, October 6, 2025 Once reserved for high-risk pregnancies, noninvasive prenatal tests (NIPTs) that screen for genetic abnormalities have been the standard of care since 2020. Most pregnant women — some 2 million a year — elect to have the test. Now a new study has found that in some cases, NIPT

In an unusual collaboration, scientists from MSK and the American Museum of Natural History looked at how the BRCA2 gene differs between humans and chimps. Mutations in this gene are linked to an increased risk of certain cancers, including breast cancer.

… Wednesday, August 31, 2022 Chimpanzees are our closest living relatives, descending from the same species as humans more than 6 million years ago. The fact that we share 98.8% of our genes with chimps explains fascinating similarities in our behaviors and our bodies. But the remaining 1.2% of genes explains

In this new expanded role, Avice Meehan will streamline communications across the Center and lead both Memorial Sloan Kettering’s Public Affairs and Marketing endeavors.

… Tuesday, March 12, 2013 Memorial Sloan Kettering Cancer Center has announced the appointment of Avice Meehan to Vice President of Communications and Chief Communications Officer. In this new expanded role, Meehan will streamline communications across the Center and lead both Memorial Sloan Kettering’

A new Sloan Kettering Institute program will enhance the use of chemical principles to investigate biological processes.

… Tuesday, August 18, 2015 Summary MSK has established the Chemical Biology Program to leverage the growing role of chemistry in biomedical research. Highlights This is the first new SKI program in more than a decade. Members will use chemical tools to study biology. Chemist Derek Tan will chair the new

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.

… Monday, December 16, 2024 Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators. Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan